Chun-hsiung Huang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Severe prostate enlargement with severe lower urinary tract symptoms in poorly controlled acromegaly successfully treated with 5α-reductase inhibitors: A 15-year longitudinal case report.
Journal: Lower urinary tract symptoms
Published: November 07, 2017
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
Journal: Oncotarget
Published: July 20, 2016
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Journal: Journal of surgical oncology
Published: September 19, 2015
Clinical predictor of survival following docetaxel-based chemotherapy.
Journal: Oncology letters
Published: November 16, 2013
Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
Journal: Annals of surgical oncology
Published: September 10, 2012
Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.
Journal: PloS one
Published: September 06, 2012
Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.
Journal: PloS one
Published: April 17, 2012
The effect of tumor location on prognosis in patients with primary ureteral urothelial carcinoma.
Journal: Urologic oncology
Published: February 07, 2012
The association of eNOS G894T polymorphism with metabolic syndrome and erectile dysfunction.
Journal: The journal of sexual medicine
Published: February 07, 2012
Neoadjuvant chemotherapy improves survival rate in advanced urothelial carcinoma.
Journal: The Kaohsiung journal of medical sciences
Published: November 21, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026